{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:28Z","timestamp":1790627968399,"version":"4.1.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,20]]},"DOI":"10.18632\/oncotarget.11133","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T12:06:46Z","timestamp":1470744406000},"page":"61500-61508","source":"Crossref","is-referenced-by-count":34,"title":["The role of nerve microenvironment for neurofibroma development"],"prefix":"10.18632","volume":"7","author":[{"given":"Chung-Ping","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amish J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid C.","family":"Booker","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu Q.","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"},{"name":"Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"},{"name":"UTSW Neurofibromatosis Clinic, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrclinonc.2013.144","article-title":"Advances in the treatment of neurofibromatosis-associated tumours","volume":"10","author":"Gutmann","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Miller","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Parada","year":"2009","journal-title":"Cell Stem Cell"},{"key":"4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Huberman","year":"2014","journal-title":"Nat Genet"},{"key":"5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Shannon","year":"2013","journal-title":"J Clin Invest"},{"key":"6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Niwa-Kawakita","year":"2013","journal-title":"J Clin Invest"},{"key":"7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1172\/JCI66167","article-title":"Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk","volume":"123","author":"Ingram","year":"2013","journal-title":"J Clin Invest"},{"key":"8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1517\/13543784.2013.772979","article-title":"Optimizing biologically targeted clinical trials for neurofibromatosis","volume":"22","author":"Packer","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathol-011811-132441","article-title":"Pathogenesis of plexiform neurofibroma: tumor-stromal\/hematopoietic interactions in tumor progression","volume":"7","author":"Clapp","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212 and c-kit-dependent bone marrow","volume":"135","author":"Vakili","year":"2008","journal-title":"Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00280-008-0881-9","article-title":"Cancer and the tumor microenvironment: a review of an essential relationship","volume":"63","author":"Johann","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"12","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1158\/0008-5472.CAN-10-4577","article-title":"Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development","volume":"71","author":"Parada","year":"2011","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Le","year":"2014","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/jnr.21226","article-title":"Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line","volume":"85","author":"Muir","year":"2007","journal-title":"J Neurosci Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z","article-title":"Long-term culture and characterization of human neurofibroma-derived Schwann cells","volume":"61","author":"Hanemann","year":"2000","journal-title":"J Neurosci Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","article-title":"Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells","volume":"158","author":"Wallace","year":"2001","journal-title":"Am J Pathol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2013.01.053","article-title":"CXCR4\/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors","volume":"152","author":"McKay","year":"2013","journal-title":"Cell"},{"key":"18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/0008-5472.CAN-13-1934","article-title":"Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors","volume":"74","author":"Le","year":"2014","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.celrep.2013.12.001","article-title":"BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction","volume":"6","author":"Le","year":"2014","journal-title":"Cell Rep"},{"key":"20","first-page":"129","article-title":"Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells","volume":"17","author":"Riccardi","year":"1981","journal-title":"Birth Defects Orig Artic Ser"},{"key":"21","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1523\/JNEUROSCI.22-22-09831.2002","article-title":"A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve","volume":"22","author":"Ratner","year":"2002","journal-title":"J Neurosci"},{"key":"22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.celrep.2013.08.033","article-title":"Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve","volume":"5","author":"Lloyd","year":"2013","journal-title":"Cell Rep"},{"key":"23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ajpath.2012.11.017","article-title":"Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis","volume":"182","author":"Carroll","year":"2013","journal-title":"Am J Pathol"},{"key":"24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/glia.20753","article-title":"Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation","volume":"56","author":"Nave","year":"2008","journal-title":"Glia"},{"key":"25","first-page":"61","article-title":"fabrication of engineered human skin","volume":"289","author":"Garlick","year":"2005","journal-title":"Methods Mol Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-60761-984-0_9","article-title":"Production of tissue-engineered skin and oral mucosa for clinical and experimental use","volume":"695","author":"Smith","year":"2011","journal-title":"Methods Mol Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/stem.1186","article-title":"Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration","volume":"30","author":"Le","year":"2012","journal-title":"Stem Cells"},{"key":"28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","article-title":"Mast cells and the neurofibroma microenvironment","volume":"116","author":"Clapp","year":"2010","journal-title":"Blood"},{"key":"29","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/nprot.2006.422","article-title":"Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny","volume":"1","author":"Miller","year":"2006","journal-title":"Nat Protoc"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:08:00Z","timestamp":1589281680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,9,20]]}},"alternative-id":["11133","27517146"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11133","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}